Actelion
Pharmaceutical ManufacturingBasel-stadt, Switzerland1001-5000 Employees
We're now part of Janssen. For future updates, please visit our LinkedIn channel: 'Janssen Pharmaceutical Companies of Johnson & Johnson'. #WithYouUntilPHIsnt
Strategic Collaborations Janssen extensively partners with academic institutions, biotech firms, and research organizations, which presents opportunities to offer innovative research tools, analytical services, and custom collaborations to support their ongoing and future partnerships.
Emerging Digital Technologies Leveraging their current tech stack, including cloud-based communication and document management solutions, offers potential for advanced digital transformation services, especially in improving internal workflows and data management efficiencies.
Focus on Women in Healthcare The launch of WiSTEM2D mentorship program highlights Janssen’s commitment to diversity and leadership development, providing opportunities for targeted healthcare education, leadership training, and diversity initiatives that your organization can support.
Expanding Research Footprint Recent partnerships with universities and biotech firms indicate Janssen's interest in expanding R&D capabilities, creating a need for specialized research, laboratory equipment, and advanced analytics solutions to enhance innovative drug discovery.
Market Position & Growth With revenues between one and ten billion dollars and a large employee base, Janssen stands as a significant player in the pharmaceutical industry, suggesting potential for high-volume sales of industry-specific products, consulting, and compliance services.
Actelion uses 8 technology products and services including accessiBe, Como, Microsoft SharePoint, and more. Explore Actelion's tech stack below.
| Actelion Email Formats | Percentage |
| First.Last@actelion.com | 42% |
| FLast@actelion.com | 9% |
| LastF@actelion.com | 4% |
| LastFirst@actelion.com | 4% |
| Last.First@actelion.com | 3% |
| First_Last@actelion.com | 3% |
| First-Last@actelion.com | 2% |
| FirstLast@actelion.com | 3% |
| F_Last@actelion.com | 2% |
| FiLast@actelion.com | 2% |
| FirstLas@actelion.com | 2% |
| First.L@actelion.com | 2% |
| LastFir@actelion.com | 2% |
| Last_First@actelion.com | 2% |
| Last.F@actelion.com | 2% |
| First-L@actelion.com | 2% |
| L.First@actelion.com | 1% |
| F.Last@actelion.com | 2% |
| FirLast@actelion.com | 1% |
| First_L@actelion.com | 2% |
| LastFi@actelion.com | 1% |
| FirstL@actelion.com | 1% |
| LFirst@actelion.com | 2% |
| F-Last@actelion.com | 1% |
| FirstLa@actelion.com | 1% |
| First.Middle@actelion.com | 1% |
| FirstMLast@actelion.com | 1% |
| First_Last@janssen.com | 42% |
| First.Last@janssen.com | 30% |
| FLast@janssen.com | 18% |
| First@janssen.com | 10% |
Pharmaceutical ManufacturingBasel-stadt, Switzerland1001-5000 Employees
We're now part of Janssen. For future updates, please visit our LinkedIn channel: 'Janssen Pharmaceutical Companies of Johnson & Johnson'. #WithYouUntilPHIsnt
Actelion's revenue is estimated to be in the range of $1B$10B
Actelion's revenue is estimated to be in the range of $1B$10B